Search results
Gateway - Quartz
Quartz· 3 days agoNovo Nordisk responded this week to the Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and raise prices. Moderna& ...
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks· 1 day agoOf these, at present, Eli Lilly appears to be a great stock to have in one’s portfolio based on its strong overall financial performance and robust drug pipeline. Lilly, with ...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 7 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
The First Three Months
The Atlantic· 5 days agoA reporter calling me at home on a holiday about a possible disease outbreak was concerning, but not that unusual. The press sometimes had better, or at...
Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday? - BioNTech (NASDAQ:BNTX)
Benzinga· 4 days agoBioNTech SE’s BNTX partner MediLink Therapeutics (Suzhou) Co., Ltd says the FDA has placed a partial clinical hold on the Phase 1 trial. The MediLink-sponsored trial evaluates ...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 2 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...
Juneteenth's viral moment and its future - Marketplace
Marketplace· 2 days agoJune 19, known as Juneteenth, has long been celebrated by African Americans. Marketplace’s Lily...
Willner & Heller LLC Purchases New Holdings in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoWillner & Heller LLC acquired a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, HoldingsChannel reports. The fund acquired 19,822 shares of the biopharmaceutical ...
7,403 Shares in Pfizer Inc. (NYSE:PFE) Bought by Gerber LLC
ETF DAILY NEWS· 4 days agoGerber LLC bought a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 7,403 shares of the biopharmaceutical company’
